genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2023
Iveric Bio
Bioprocessing
Conscious Re-Coupling: M&A Comes Back Surely, If Slowly
Drug Discovery
Apellis Axing 25% of Staff, Shifting Resources to GA Drug
Drug Discovery
StockWatch: Apellis Shares Nosedive 73% on Safety Concerns
Drug Discovery
Astellas to Acquire Iveric Bio for $5.9B, Expanding Eye Disease Pipeline
GEN Edge
Opus Genetics Acquires Two Gene Therapy Candidates for Inherited Retinal Diseases
Genome Editing
Ophthotech Licenses Rights to Develop AAV Gene Therapies for Best Disease from Penn, U. Florida
Drug Discovery
Ophthotech Expands Eye Disease Pipelines of Small Molecule, Gene Therapy Candidates
Industry News
Anticipating Third Phase III Failure, Ophthotech and Novartis Rework Fovista Accord
Scroll Up
Scroll Up
